<p>卡地纳健康（NYSE:CAH - 获取免费报告）于周二发布了季度收益数据。该公司报告本季度每股收益（EPS）为 2.08 美元，超出市场共识预期的 2.03 美元，超出幅度为 0.05 美元，Briefing.com 报道。卡地纳健康的股本回报率为负的 68.84%，净利润率为 0.70%。该公司本季度的收入为 601.6 亿美元，而市场共识预期为 609.1 亿美元。在去年同期，该公司的每股收益为 1.84 美元。与去年同期相比，该公司的季度收入增长了 0.5%。卡地纳健康更新了其 2026 财年的指引，预计每股收益在 9.300-9.500 之间。</p>
<p>获取 <strong>卡地纳健康</strong> 的提醒：</p>
<h2>卡地纳健康股票表现</h2>
<ul>
<li>对市场感到怀疑？3 只股票帮助你渡过恐惧、不确定性和怀疑</li>
</ul>
<p>卡地纳健康的股票周二开盘价为 158.07 美元。该股票的 50 日移动平均价为 160.10 美元，200 日移动平均价为 144.16 美元。该公司的市值为 377.3 亿美元，市盈率为 24.66，PEG 比率为 1.56，贝塔值为 0.67。卡地纳健康的 52 周低点为 100.07 美元，52 周高点为 168.44 美元。</p>
<h2>分析师评级上调与下调</h2>
<p>多位分析师对该公司进行了评估。富国银行将卡地纳健康的评级从 “持平” 上调至 “增持”，并在 6 月 3 日的研究报告中将其目标价从 136.00 美元提高至 179.00 美元。罗伯特·W·贝尔德将卡地纳健康的目标价从 156.00 美元上调至 170.00 美元，并在 5 月 2 日的报告中给予该公司 “跑赢大盘” 的评级。摩根士丹利在周二的报告中重申了对卡地纳健康股票的 “增持” 评级。瑞银集团在周二的报告中重申了对卡地纳健康股票的 “买入” 评级。最后，花旗集团在 6 月 13 日的研究报告中重申了 “中性” 评级，并将卡地纳健康股票的目标价从 157.00 美元上调至 170.00 美元。三位研究分析师对该股票给予了持有评级，十二位分析师给予了买入评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 158.07 美元。</p>
<ul>
<li>医疗技术股票受益于急性护理需求上升</li>
</ul>
<p><strong>查看我们对卡地纳健康的最新股票分析</strong></p>
<h2>对卡地纳健康的对冲基金看法</h2>
<p>一家对冲基金最近增加了对卡地纳健康股票的持股。Jones Financial Companies Lllp 在第一季度将其在卡地纳健康（NYSE:CAH - 免费报告）股票中的持股比例提高了 198.3%，根据其最近向证券交易委员会的披露。该基金在本季度购买了额外的 14,034 股后，持有该公司 21,112 股股票。根据其最近的 SEC 文件，Jones Financial Companies Lllp 在卡地纳健康的持股价值为 27,000 美元。对冲基金和其他机构投资者持有该公司 87.17% 的股票。</p>
<h2>关于卡地纳健康</h2>
<p>（获取免费报告）</p>
<ul>
<li>对于卡地纳健康，证明将在其表现中体现</li>
</ul>
<p>卡地纳健康公司在美国、加拿大、欧洲、亚洲及国际上运营，提供医疗服务和产品。它为医院、医疗系统、药房、门诊手术中心、临床实验室、医生办公室和家庭患者提供定制解决方案。</p>
<h2>阅读更多</h2>
<ul>
<li>我们更看好的五只股票超过卡地纳健康</li>
<li>如何使用 MarketBeat Excel 股息计算器</li>
<li>MP 材料股票因稀土热潮创下新高</li>
<li>什么是股息竞争者？投资股息竞争者</li>
<li>AMD 为市场份额增长铺平道路：股票反弹刚刚开始</li>
<li>股票评级和推荐：理解分析师评级</li>
<li>IBM：上次发生这种情况时，股票上涨了 35%</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在卡地纳健康吗？</h2>
<p>在你考虑卡地纳健康之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而卡地纳健康并不在名单上。</p>
<p>虽然卡地纳健康目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

卡地纳健康

<p>卡地纳健康（NYSE:CAH）报告的季度每股收益为 2.08 美元，超出预期 0.05 美元。收入为 601.6 亿美元，略低于预测的 609.1 亿美元。该公司的净利润率为 0.70%，股本回报率为负的 68.84%。与去年同期相比，收入增长了 0.5%。卡地纳健康更新了其 2026 财年的每股收益指引至 9.300-9.500。分析师普遍对该股票给予积极评级，目标价共识为 158.07 美元，大多数分析师建议买入</p>

<p>Cardinal Health (NYSE:CAH - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $2.08 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.03 by $0.05, Briefing.com reports. Cardinal Health had a negative return on equity of 68.84% and a net margin of 0.70%. The firm had revenue of $60.16 billion for the quarter, compared to the consensus estimate of $60.91 billion. During the same quarter in the previous year, the business earned $1.84 EPS. The company's quarterly revenue was up .5% compared to the same quarter last year. Cardinal Health updated its FY 2026 guidance to 9.300-9.500 EPS.</p>
<div class="lb-trans"><p>卡地纳健康（NYSE:CAH - 获取免费报告）于周二发布了季度收益数据。该公司报告本季度每股收益（EPS）为 2.08 美元，超出市场共识预期的 2.03 美元，超出幅度为 0.05 美元，Briefing.com 报道。卡地纳健康的股本回报率为负的 68.84%，净利润率为 0.70%。该公司本季度的收入为 601.6 亿美元，而市场共识预期为 609.1 亿美元。在去年同期，该公司的每股收益为 1.84 美元。与去年同期相比，该公司的季度收入增长了 0.5%。卡地纳健康更新了其 2026 财年的指引，预计每股收益在 9.300-9.500 之间。</p>
</div><p>Get <strong>Cardinal Health</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>卡地纳健康</strong> 的提醒：</p>
</div><h2>Cardinal Health Stock Performance</h2>
<div class="lb-trans"><h2>卡地纳健康股票表现</h2>
</div><ul>
<li>Doubt the Market? 3 Stocks to Rideout Fear, Uncertainty and Doubt</li>
</ul>
<div class="lb-trans"><ul>
<li>对市场感到怀疑？3 只股票帮助你渡过恐惧、不确定性和怀疑</li>
</ul>
</div><p>Cardinal Health stock opened at $158.07 on Tuesday. The stock has a fifty day moving average of $160.10 and a two-hundred day moving average of $144.16. The company has a market capitalization of $37.73 billion, a price-to-earnings ratio of 24.66, a PEG ratio of 1.56 and a beta of 0.67. Cardinal Health has a fifty-two week low of $100.07 and a fifty-two week high of $168.44.</p>
<div class="lb-trans"><p>卡地纳健康的股票周二开盘价为 158.07 美元。该股票的 50 日移动平均价为 160.10 美元，200 日移动平均价为 144.16 美元。该公司的市值为 377.3 亿美元，市盈率为 24.66，PEG 比率为 1.56，贝塔值为 0.67。卡地纳健康的 52 周低点为 100.07 美元，52 周高点为 168.44 美元。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析师评级上调与下调</h2>
</div><p>A number of analysts have weighed in on the company. Wells Fargo &amp; Company raised Cardinal Health from an &#34;equal weight&#34; rating to an &#34;overweight&#34; rating and increased their price objective for the stock from $136.00 to $179.00 in a research report on Tuesday, June 3rd. Robert W. Baird raised their price target on Cardinal Health from $156.00 to $170.00 and gave the company an &#34;outperform&#34; rating in a report on Friday, May 2nd. Morgan Stanley reissued an &#34;overweight&#34; rating on shares of Cardinal Health in a report on Tuesday. UBS Group reissued a &#34;buy&#34; rating on shares of Cardinal Health in a report on Tuesday. Finally, Citigroup reaffirmed a &#34;neutral&#34; rating and issued a $170.00 price objective (up from $157.00) on shares of Cardinal Health in a research note on Friday, June 13th. Three research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $158.07.</p>
<div class="lb-trans"><p>多位分析师对该公司进行了评估。富国银行将卡地纳健康的评级从 “持平” 上调至 “增持”，并在 6 月 3 日的研究报告中将其目标价从 136.00 美元提高至 179.00 美元。罗伯特·W·贝尔德将卡地纳健康的目标价从 156.00 美元上调至 170.00 美元，并在 5 月 2 日的报告中给予该公司 “跑赢大盘” 的评级。摩根士丹利在周二的报告中重申了对卡地纳健康股票的 “增持” 评级。瑞银集团在周二的报告中重申了对卡地纳健康股票的 “买入” 评级。最后，花旗集团在 6 月 13 日的研究报告中重申了 “中性” 评级，并将卡地纳健康股票的目标价从 157.00 美元上调至 170.00 美元。三位研究分析师对该股票给予了持有评级，十二位分析师给予了买入评级。根据 MarketBeat 的数据，该股票目前的平均评级为 “适度买入”，共识目标价为 158.07 美元。</p>
</div><ul>
<li>Medical Technology Stock Benefits from Rising Acute Care Demand</li>
</ul>
<div class="lb-trans"><ul>
<li>医疗技术股票受益于急性护理需求上升</li>
</ul>
</div><p><strong>Check Out Our Latest Stock Analysis on Cardinal Health</strong></p>
<div class="lb-trans"><p><strong>查看我们对卡地纳健康的最新股票分析</strong></p>
</div><h2>Hedge Funds Weigh In On Cardinal Health</h2>
<div class="lb-trans"><h2>对卡地纳健康的对冲基金看法</h2>
</div><p>A hedge fund recently raised its stake in Cardinal Health stock. Jones Financial Companies Lllp lifted its holdings in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 198.3% during the 1st quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The fund owned 21,112 shares of the company's stock after purchasing an additional 14,034 shares during the quarter. Jones Financial Companies Lllp's holdings in Cardinal Health were worth $27,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 87.17% of the company's stock.</p>
<div class="lb-trans"><p>一家对冲基金最近增加了对卡地纳健康股票的持股。Jones Financial Companies Lllp 在第一季度将其在卡地纳健康（NYSE:CAH - 免费报告）股票中的持股比例提高了 198.3%，根据其最近向证券交易委员会的披露。该基金在本季度购买了额外的 14,034 股后，持有该公司 21,112 股股票。根据其最近的 SEC 文件，Jones Financial Companies Lllp 在卡地纳健康的持股价值为 27,000 美元。对冲基金和其他机构投资者持有该公司 87.17% 的股票。</p>
</div><h2>About Cardinal Health</h2>
<div class="lb-trans"><h2>关于卡地纳健康</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><ul>
<li>For Cardinal Health, the Proof Will be in Its Performance</li>
</ul>
<div class="lb-trans"><ul>
<li>对于卡地纳健康，证明将在其表现中体现</li>
</ul>
</div><p>Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.</p>
<div class="lb-trans"><p>卡地纳健康公司在美国、加拿大、欧洲、亚洲及国际上运营，提供医疗服务和产品。它为医院、医疗系统、药房、门诊手术中心、临床实验室、医生办公室和家庭患者提供定制解决方案。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>阅读更多</h2>
</div><ul>
<li>Five stocks we like better than Cardinal Health</li>
<li>How to Use the MarketBeat Excel Dividend Calculator</li>
<li>MP Materials Stock Rides Rare Earth Boom to New Highs</li>
<li>What Are Dividend Contenders? Investing in Dividend Contenders</li>
<li>AMD Paves Path for Market Share Gains: Stock Rally Has Just Begun</li>
<li>Stock Ratings and Recommendations: Understanding Analyst Ratings</li>
<li>IBM: The Last Time This Happened, the Stock Rallied 35%</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过卡地纳健康</li>
<li>如何使用 MarketBeat Excel 股息计算器</li>
<li>MP 材料股票因稀土热潮创下新高</li>
<li>什么是股息竞争者？投资股息竞争者</li>
<li>AMD 为市场份额增长铺平道路：股票反弹刚刚开始</li>
<li>股票评级和推荐：理解分析师评级</li>
<li>IBM：上次发生这种情况时，股票上涨了 35%</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNBSA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NYSE&amp;Symbol=CAH"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Cardinal Health Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在卡地纳健康吗？</h2>
</div><p>Before you consider Cardinal Health, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑卡地纳健康之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐的股票。MarketBeat 已识别出五只顶级分析师正在悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而卡地纳健康并不在名单上。</p>
</div><p>While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然卡地纳健康目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

卡地纳健康（NYSE:CAH）公布季度财报，每股收益超出预期 0.05 美元